Related Experiment Video

Updated: Aug 12, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

Diagnosis of thromboembolic disease during infancy and childhood

A H Sutor1, M Uhl

  • 1Kinderklinik der Albert-Ludwigs-Universität Freiburg, Germany.

Seminars in Thrombosis and Hemostasis
|January 1, 1997
PubMed

Insights

Pediatric thromboembolism is rising, differing from adults. Congenital factors like activated protein C (APC) resistance and acquired risks such as central venous lines are key concerns in children.

Area of Science:

  • Pediatric Hematology
  • Thrombosis Research
  • Vascular Medicine

Background:

  • Thromboembolic disorders are increasingly recognized in pediatric patients, with unique age-related risk factors distinct from adults.
  • Congenital prethrombotic disorders, particularly activated protein C (APC) resistance, are significant contributors to pediatric thrombosis.
  • Acquired risk factors, including central venous lines, cardiac conditions, and nephrotic syndrome, further elevate thrombosis risk in children.

Purpose of the Study:

  • To highlight the distinct features and rising incidence of thromboembolic disorders in pediatric populations.
  • To identify key congenital and acquired risk factors specific to children.
  • To emphasize the need for age-appropriate diagnostic and management strategies for pediatric thrombosis.

Main Methods:

  • Review of existing literature on pediatric thromboembolism.
  • Analysis of age-specific risk factors, including congenital and acquired conditions.
  • Examination of clinical manifestations and diagnostic challenges in children.

Main Results:

  • Congenital prethrombotic states and APC resistance are prevalent in pediatric thrombosis.
  • Central venous line thrombosis, cardiac diseases, and nephrotic syndrome are significant acquired risks.
  • Neonatal period presents the highest risk, influenced by congenital factors and catheter use.
  • Acute lymphoblastic leukemia, especially with APC resistance, increases thrombosis risk.

Conclusions:

  • Pediatric thromboembolism requires specialized approaches due to unique pathophysiology and risk factors.
  • Early identification of congenital and acquired risks is crucial for effective prevention and management.
  • Comprehensive laboratory and diagnostic evaluations are essential for accurate diagnosis in pediatric thrombosis.

More Related Videos

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...